2013 CORE (China Outcomes Research and Evidence Based Medicine) Summit was successfully held this month in Shanghai Gran Melia Hotel. Since its inaugural event in 2011, CORE Summit has attracted increasing number of experts, speakers and delegates from within and outside of China each year, and has become one of the most important events in promoting evidence based medicine in China.
At this year's conference, Director of AHRQ, Carolyn Clancy, MD, Director of Epidemiology of FDA, Danica Marinac-Dabic, MD, Senior Executive Editor of The Lance, William Summerskill, MD, President and CEO of Joslin Diabetes Center of Harvard Medical School, Mr. John Brooks, were among the distinguished speakers from the international communities.
There were clearly increased interest and attention on health economics and big data related topics, represented by both the level and capacity of the speakers and the level of enthusiasm and knowledge among the audience. The most discussed topics included social insurance and pricing, policy and reform under the new administration, as well as electronic medical records, hospital consortium and partnership, and clinical outcomes data collection.
Patient registry was one of the big topics this year. The discussion on registry was augmented by the introduction of NCDR (National Cardiovascular Data Registry) organized by American College of Cardiology, and the CCMR (China Cardiometabolic Registries) organized by Chinese Medical Doctor Association and VitalStrategic Research Institute. NCDR and CCMR represent the largest registry series in the US and China in the cardiovascular and metabolic disease areas, respectively.
The audiences of the 2013 CORE Summit included the stake holders from medical societies, pharmaceutical industry, medical device industry, and government owned research institutions. The big multinational pharma, including Bristol Myers Squibb, Pfizer, Sanofi, Eli Lilly, Bayer, Abbott, Merck, and the international organizations who are in the field of outcomes research and health economics, such as IMS Health, Quintilese Outcome, Analysis Group, and Aldelphi.The organizers of CORE Summit are Chinese Medical Doctor Association, an organization that has a reach to 2 million licensed medical physicians in China, and VitalStrategic Research Institute (VSRI), a US based independent research organization that operates exclusively in China.
VSRI is one of the leaders in clinical research, outcomes research, health informatics, and health economics in China. It has successfully launched CCMR, the largest patient registry series in China, developed a network of over 500 hospitals and clinics where its EDC is implemented, and a strong collaborative relationship with various medical societies and government agencies Based on the success of the past three years, according to the Chairman of the CORE Advisory Council, Dr. Danyi Zhang, President and Chief Medical Officer of VitalStrategic Research Institute, the 2014 CORE Summit will place more weight on the topic of eHealth, eClinical and the practice of using electronic medical records for measuring clinical outcomes, healthcare quality and patient engagement. For more information, please contact email@example.com.
(Viewers from China please click here)